Paradigm Biocapital Advisors LP - 30 Sep 2025 SCHEDULE 13G/A Report for Cidara Therapeutics, Inc. Common Stock, $0.0001 par value per share (CDTX)

Filing Manager: Paradigm Biocapital Advisors LP
Reporting Manager: Paradigm BioCapital Advisors LP
Security: Cidara Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: CDTX
Shares outstanding: 29,126,182 shares
Disclosed Ownership: 961,164 shares
Ownership: 3.3%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 16:34:04 UTC
Date of event: 30 Sep 2025
Previous filing: 30 Jul 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Paradigm BioCapital Advisors LP	3.3%	961,164	961,164	/s/ David K. Kim	David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC	3.3%	961,164	961,164	/s/ David K. Kim	David K. Kim / Authorized Signatory
Senai Asefaw, M.D.	3.3%	961,164	961,164	/s/ Senai Asefaw, M.D.	N/A
Paradigm BioCapital International Fund Ltd.	2.9%	848,515	848,515	/s/ David K. Kim	David K. Kim / Authorized Signatory